Olivia Hunt


Authored Content

New USPSTF breast cancer screening recommendations may not address the disparities experienced by Black women.

When utilizing and acquiring data, life sciences companies should consider these top questions and key implications for their 2024–2025 strategic plans.

A major cyberattack has disrupted medical and pharmacy claims processing and is expected to impact how medical claims are submitted and paid in the future.

Continued emphasis on diabetes management technology and patient-centered care in updated clinical management standards highlight the importance of advancing quality measurement.

Innovative research methods can be used to measure the total burden of rare disease, including direct medical costs, indirect costs, and overall life impacts.